Articles

Novel Oral Antiplatelet Agents

Citation:

European Cardiology 2011;7(4):294–300

Cell-specific Mathematical Modelling of hiPSC-CMs and Its Potential for Prediction of Drug Testing

Citation:

European Cardiology Review 2018;13(2):131.

Early, Optimal Blood Pressure Control for High-risk Patients

Citation:

European Cardiovascular Disease 2006;2(1):1–5

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis

Citation:

European Cardiology Review 2020;15:e37.

Non-invasive Risk Stratification Early After a Myocardial Infarction - The Risk Estimation Following Infarction Non-invasive Evaluation (REFINE) Study

Citation:

European Cardiology 2008;4(1):21–2

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Published:

18 December 2019

Citation:

European Cardiology Review 2019;14(3):201

Analysis of the Effects of EPA and DHA on Cardiomyocyte hypertrophy

Citation:

European Cardiology Review 2018;13(2):121.

Magnetic Resonance Angiography Using the Intravascular Contrast Agent Vasovist®

Citation:

European Cardiovascular Disease 2006;2(1):49–52

Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome

Citation:

European Cardiology Review 2020;15:e27.

The Mechanism of Hey2 Expression in Cardiac Development

Citation:

European Cardiology Review 2018;13(2):128.